Nazira Amra, MD
Chief Commercial Strategy Officer
Nazira is a physician and senior commercial executive with more than 25 years of experience across global pharmaceutical, biotechnology, and emerging techbio companies. She brings deep expertise in cardiometabolic disease, including MASH, and has led multiple global product launches.
Nazira previously held multiple senior leadership roles at Sanofi, where she led global franchises and regional operations, before transitioning to biotechnology in 2015. After leading MASH launch readiness at Intercept Pharmaceuticals, she transitioned to commercial strategy at Exscientia, an AI-driven drug discovery company, ahead of its IPO, and has since advised life sciences companies on strategy, financing, and organizational design.
She holds a BSc (Honors) in Biology and an M.D. from McGill University, as well as an M.B.A from INSEAD.